Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Immunomedics
Sort By
Newest First
1 / 1
1 / 1
M&A
Gilead Sciences to Acquire Immunomedics
Gilead Sciences
PR-M09-20-NI-18
Sep 15, 2020
Antibody–Drug Conjugates
Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life
Loretta Itri, M.D., F.A.C.P.,; Usama Malik
Immunomedics
PAP-Q2-20-CL-012
Jul 01, 2020
